Can J&J's novel partnering strategy to access early innovation effectively translate into new products?




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Can J&J's novel partnering strategy to access early innovation effectively translate into new products?
Released on: August 31, 2014. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    "As J&J Innovation what we try to bring to the table is strategic insight, the willingness to really collaborate with our partners.
  • Summary
  • Transcript
  • Participants
  • Company
"As J&J Innovation what we try to bring to the table is strategic insight, the willingness to really collaborate with our partners...it's about bringing together the right people to design the right experiments" Patrick Verheyen, Head, J&J Innovation, Europe. During BioTrinity, Fintan Walton talked with Patrick about the J&J Innovation Business models, including their collaboration with Index Ventures and GSK on IL V1 and also their novel collaboration with Johnson & Johnson Development Corporation (JJDC), the Office of the Chief Scientist in Israel, Takeda Pharmaceutical Company, and OrbiMed Israel Partners in Israel.
"As J&J Innovation what we try to bring to the table is strategic insight, the willingness to really collaborate with our partners...it's about bringing together the right people to design the right experiments" Patrick Verheyen, Head, J&J Innovation, Europe. During BioTrinity, Fintan Walton talked with Patrick about the J&J Innovation Business models, including their collaboration with Index Ventures and GSK on IL V1 and also their novel collaboration with Johnson & Johnson Development Corporation (JJDC), the Office of the Chief Scientist in Israel, Takeda Pharmaceutical Company, and OrbiMed Israel Partners in Israel.
Patrick Verheyen
J&J Innovation
Johnson & Johnson (J&J)
Johnson & Johnson is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson is known for its corporate reputation, consistently ranking at the top of Harris Interactive's National Corporate Reputation Survey, ranking as the world's most respected company by Barron's Magazine, and was the first corporation awarded the Benjamin Franklin Award for Public Diplomacy by the U.S. State Department for its funding of international education programs.